Stroke · Post‐menopausal women without prior cardiovascular disease
Hormone therapy leads to higher stroke compared with placebo (high certainty).
1 finding from 1 review
Stroke · Post‐menopausal women with pre‐exisiting cardiovascular disease
Hormone therapy showed no clear difference in stroke compared with placebo (moderate certainty).
1 finding from 1 review
Stroke · patients with heart failure
Coenzyme Q10 showed no clear difference in stroke compared with placebo or conventional therapy (low certainty).
1 finding from 1 review
Intervention not reported
Stroke · Post‐menopausal women
The intervention showed no clear difference in stroke (high certainty).
1 finding from 1 review
Intervention not reported
Stroke · Post‐menopausal women
The intervention leads to higher stroke (high certainty).
1 finding from 1 review
Intervention not reported
Stroke · patients undergoing cardiac surgery
The intervention showed no clear difference in stroke (moderate certainty).
1 finding from 1 review
Composite endpoint of thromboembolic events (stroke or systemic embolism), major bleeding events, and all‐cause mortality · adults with arrhythmias undergoing catheter ablation
Interrupted may leads to lower composite endpoint of thromboembolic events (stroke or systemic… compared with uninterrupted anticoagulation therapy (low certainty).
1 finding from 1 review
Intervention not reported
ASCVD event, such as fatal or non‐fatal myocardial infarction or stroke. Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention showed no clear difference in ASCVD event, such as fatal or non‐fatal myocardial infarction or… (low certainty).
1 finding from 1 review